Prudential Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $222M | Buy |
1,759,349
+484,250
| +38% | +$63.8M | 0.24% | 74 |
|
|
2026
Q1 | $178M | Sell |
1,275,099
-755,421
| -37% | -$106M | 0.22% | 78 |
|
|
2025
Q4 | $249M | Sell |
2,030,520
-322,019
| -14% | -$39.1M | 0.3% | 55 |
|
|
2025
Q3 | $261M | Buy |
2,352,539
+644,789
| +38% | +$73.3M | 0.31% | 51 |
|
|
2025
Q2 | $189M | Buy |
1,707,750
+486,379
| +40% | +$51.8M | 0.24% | 72 |
|
|
2025
Q1 | $137M | Buy |
1,221,371
+240,118
| +24% | +$24.8M | 0.2% | 94 |
|
|
2024
Q4 | $90.6M | Sell |
981,253
-45,470
| -4% | -$4.09M | 0.12% | 140 |
|
|
2024
Q3 | $82.2M | Buy |
1,026,723
+172,477
| +20% | +$13.2M | 0.12% | 160 |
|
|
2024
Q2 | $58.6M | Sell |
854,246
-60,623
| -7% | -$4.05M | 0.09% | 198 |
|
|
2024
Q1 | $67M | Sell |
914,869
-486,278
| -35% | -$37.4M | 0.09% | 199 |
|
|
2023
Q4 | $113M | Buy |
1,401,147
+122,750
| +10% | +$9.55M | 0.17% | 117 |
|
|
2023
Q3 | $95.8M | Sell |
1,278,397
-767,645
| -38% | -$59M | 0.15% | 137 |
|
|
2023
Q2 | $158M | Sell |
2,046,042
-68,625
| -3% | -$5.47M | 0.23% | 87 |
|
|
2023
Q1 | $175M | Sell |
2,114,667
-15,377
| -0.7% | -$1.27M | 0.27% | 69 |
|
|
2022
Q4 | $183M | Sell |
2,130,044
-584,634
| -22% | -$46.3M | 0.31% | 69 |
|
|
2022
Q3 | $168M | Buy |
2,714,678
+21,664
| +0.8% | +$1.37M | 0.28% | 71 |
|
|
2022
Q2 | $166M | Buy |
2,693,014
+521,595
| +24% | +$32.3M | 0.26% | 78 |
|
|
2022
Q1 | $129M | Buy |
2,171,419
+515,307
| +31% | +$32.9M | 0.17% | 122 |
|
|
2021
Q4 | $113M | Sell |
1,656,112
-295,051
| -15% | -$20.3M | 0.14% | 147 |
|
|
2021
Q3 | $139M | Sell |
1,951,163
-405,695
| -17% | -$28.5M | 0.19% | 113 |
|
|
2021
Q2 | $162M | Sell |
2,356,858
-1,275,877
| -35% | -$85.2M | 0.22% | 89 |
|
|
2021
Q1 | $235M | Buy |
3,632,735
+85,490
| +2% | +$5.51M | 0.35% | 63 |
|
|
2020
Q4 | $207M | Buy |
3,547,245
+186,269
| +6% | +$11.2M | 0.35% | 62 |
|
|
2020
Q3 | $212M | Buy |
3,360,976
+1,172,819
| +54% | +$81.3M | 0.4% | 47 |
|
|
2020
Q2 | $168M | Sell |
2,188,157
-439,362
| -17% | -$33.7M | 0.32% | 65 |
|
|
2020
Q1 | $196M | Sell |
2,627,519
-1,615,763
| -38% | -$112M | 0.43% | 43 |
|
|
2019
Q4 | $276M | Sell |
4,243,282
-629,266
| -13% | -$41M | 0.41% | 41 |
|
|
2019
Q3 | $309M | Buy |
4,872,548
+229,680
| +5% | +$15M | 0.49% | 33 |
|
|
2019
Q2 | $314M | Buy |
4,642,868
+536,908
| +13% | +$35.3M | 0.49% | 37 |
|
|
2019
Q1 | $267M | Sell |
4,105,960
-342,225
| -8% | -$22.7M | 0.44% | 34 |
|
|
2018
Q4 | $278M | Buy |
4,448,185
+461,442
| +12% | +$32.3M | 0.49% | 30 |
|
|
2018
Q3 | $308M | Buy |
3,986,743
+1,401,485
| +54% | +$106M | 0.45% | 32 |
|
|
2018
Q2 | $183M | Sell |
2,585,258
-98,155
| -4% | -$6.93M | 0.27% | 73 |
|
|
2018
Q1 | $202M | Sell |
2,683,413
-1,657,894
| -38% | -$132M | 0.31% | 65 |
|
|
2017
Q4 | $311M | Buy |
4,341,307
+680,071
| +19% | +$51.6M | 0.42% | 42 |
|
|
2017
Q3 | $297M | Buy |
3,661,236
+373,099
| +11% | +$28.5M | 0.43% | 42 |
|
|
2017
Q2 | $233M | Sell |
3,288,137
-8,636
| -0.3% | -$575K | 0.35% | 57 |
|
|
2017
Q1 | $224M | Sell |
3,296,773
-165,380
| -5% | -$11.6M | 0.35% | 53 |
|
|
2016
Q4 | $248M | Sell |
3,462,153
-390,730
| -10% | -$29M | 0.4% | 41 |
|
|
2016
Q3 | $305M | Sell |
3,852,883
-217,725
| -5% | -$17.7M | 0.5% | 33 |
|
|
2016
Q2 | $340M | Buy |
4,070,608
+254,200
| +7% | +$22.6M | 0.57% | 32 |
|
|
2016
Q1 | $351M | Buy |
3,816,408
+410,120
| +12% | +$37M | 0.63% | 25 |
|
|
2015
Q4 | $345M | Sell |
3,406,288
-189,210
| -5% | -$19.7M | 0.62% | 28 |
|
|
2015
Q3 | $353M | Buy |
3,595,498
+34,120
| +1% | +$3.79M | 0.7% | 23 |
|
|
2015
Q2 | $417M | Buy |
3,561,378
+339,300
| +11% | +$37.1M | 0.74% | 17 |
|
|
2015
Q1 | $316M | Sell |
3,222,078
-234,590
| -7% | -$23.8M | 0.55% | 29 |
|
|
2014
Q4 | $326M | Buy |
3,456,668
+4,170
| +0.1% | +$431K | 0.59% | 29 |
|
|
2014
Q3 | $368M | Sell |
3,452,498
-13,562
| -0.4% | -$1.33M | 0.69% | 23 |
|
|
2014
Q2 | $287M | Buy |
3,466,060
+621,922
| +22% | +$48.4M | 0.51% | 38 |
|
|
2014
Q1 | $202M | Buy |
2,844,138
+405,450
| +17% | +$31.8M | 0.38% | 49 |
|
|
2013
Q4 | $183M | Buy |
2,438,688
+411,650
| +20% | +$28.7M | 0.36% | 54 |
|
|
2013
Q3 | $127M | Sell |
2,027,038
-22,110
| -1% | -$1.32M | 0.27% | 76 |
|
|
2013
Q2 | $105M | Buy |
+2,049,148
| New | +$107M | 0.23% | 99 |
|
Other funds holding GILD
Prudential Financial's GILD Position: Q2 2026 in Review
Prudential Financial increased its Gilead Sciences (GILD) stake by 38% in Q2 2026, buying an estimated $63.8M and bringing the position to 1,759,349 shares worth $222M. The position accounts for 0.24% of the portfolio, ranked #74.
Prudential Financial first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $417M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Prudential Financial held 1,759,349 shares of Gilead Sciences worth $222M as of Q2 2026.
- Prudential Financial bought 484,250 Gilead Sciences shares in Q2 2026, an estimated $63.8M.
- Gilead Sciences made up 0.24% of Prudential Financial's portfolio in Q2 2026, its #74 holding.
- Prudential Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Prudential Financial's Gilead Sciences position peaked at $417M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.